Regenosca SA

Regenosca SA

Herstellung medizinischer Geräte

Lausanne, Vaud 263 Follower:innen

Meshes for soft tissue repair

Info

Our technology platform TissueSpan creates regenerative and off-the shelf meshes for soft tissue repair. Proof-of-concept is validated in an ongoing First-in-Human study where Regenosca's implants were successfully used to repair a narrowing of the urinary passage, a so called urethral stricture. Thanks to the mesh, tissue healing was induced at the implantation site! The current gold standard for urethral stricture repair is the use of patient's own inner mouth tissue. This second operation site creates additional pain, increases the risk of complications, and prolongates the overall surgery time. No surgeon should be obliged in the future to harvest healthy tissue from the patient's body and patients shall get access to less invasive and efficient treatments. Regenosca's regenerative and ready-to-use TissueSpan meshes will revolutionize the repair of the urinary passage and present a promise for soft tissue repair in general.

Branche
Herstellung medizinischer Geräte
Größe
2–10 Beschäftigte
Hauptsitz
Lausanne, Vaud
Art
Privatunternehmen

Orte

Beschäftigte von Regenosca SA

Updates

Ähnliche Seiten

Finanzierung

Regenosca SA Insgesamt 5 Finanzierungsrunden

Letzte Runde

Pre-Seed

1.125.641,00 $

Weitere Informationen auf Crunchbase